相似文献
1
Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection.
J Clin Microbiol. 1983 Aug;18(2):305-9. doi: 10.1128/jcm.18.2.305-309.1983.
2
Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation.
Transplantation. 2018 Oct;102(10):1717-1723. doi: 10.1097/TP.0000000000002173.
3
Passively acquired antibody to hepatitis B surface antigen. Pitfall in evaluating immunity to hepatitis B viral infections.
Arch Pathol Lab Med. 1989 May;113(5):529-31.
4
Acute hepatitis B viral infection in a patient with anti-HBs.
J Med Virol. 1991 Oct;35(2):133-5. doi: 10.1002/jmv.1890350211.
5
Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.
J Med Virol. 1985 May;16(1):89-96. doi: 10.1002/jmv.1890160112.
6
A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
J Infect Dis. 2016 Jul 15;214(2):273-80. doi: 10.1093/infdis/jiw142. Epub 2016 Apr 7.
7
Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.
Clin Exp Immunol. 1996 Jul;105(1):52-8. doi: 10.1046/j.1365-2249.1996.d01-732.x.
8
Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.
Arch Virol. 2019 Nov;164(11):2645-2658. doi: 10.1007/s00705-019-04369-9. Epub 2019 Aug 9.
9
Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
J Gastroenterol Hepatol. 2004 Aug;19(8):847-53. doi: 10.1111/j.1440-1746.2003.03303.x.
10
De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
Antivir Ther. 2011;16(4):479-87. doi: 10.3851/IMP1771.
引用本文的文献
1
Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.
World J Gastroenterol. 2006 Jul 14;12(26):4219-23. doi: 10.3748/wjg.v12.i26.4219.
2
Clinical significance of concurrent hepatitis B surface antigen and antibody positivity.
Dig Dis Sci. 1986 Jun;31(6):620-4. doi: 10.1007/BF01318693.
3
4
Exposure to hepatitis B: review of current concepts.
Bull N Y Acad Med. 1989 Sep;65(7):741-56.
本文引用的文献
1
Reexamination of hepatitis B virus subtypes and e-antigen expression by radioimmunoassays.
J Med Virol. 1982;10(1):1-9. doi: 10.1002/jmv.1890100102.
2
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
Hepatology. 1981 Sep-Oct;1(5):377-85. doi: 10.1002/hep.1840010502.
3
Serologic markers of hepatitis B virus infection.
Annu Rev Med. 1981;32:1-11. doi: 10.1146/annurev.me.32.020181.000245.
4
Type B hepatitis: a review of current prospects for a safe and effective vaccine.
Rev Infect Dis. 1980 May-Jun;2(3):470-92. doi: 10.1093/clinids/2.3.470.
5
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
N Engl J Med. 1980 Oct 9;303(15):833-41. doi: 10.1056/NEJM198010093031501.
6
Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
N Engl J Med. 1982 Dec 9;307(24):1481-6. doi: 10.1056/NEJM198212093072403.
7
8
9
Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease?
J Med Virol. 1982;10(2):83-90. doi: 10.1002/jmv.1890100202.
Zotero 插件